After fertilization, embryos are not necessarily transferred at the same developmental stage in every IVF cycle.
Some embryos are transferred approximately three days after fertilization, while they are still at the cleavage stage.
In other cycles, embryos remain in the laboratory until Day 5 or Day 6, when some develop into blastocysts.
This leads to an understandable question:
Is Day 5 embryo transfer always better than Day 3?
The answer is no.
Blastocyst-stage transfer can offer higher live-birth rates per fresh transfer, particularly in women with a good prognosis and several developing embryos.
However, extended culture also increases the possibility that no embryo will remain available for transfer, which can become particularly important when only a few embryos are available.
The decision is therefore not simply about which embryo transfer day has the highest pregnancy percentage.
Two different outcomes need to be distinguished:
Success per individual embryo transfer.
And cumulative chance of live birth from all embryos created after one oocyte retrieval.
The updated 2026 Cochrane review found that blastocyst-stage transfer may slightly improve cumulative live birth within the first 12 months in women with a good prognosis and probably improves live birth after fresh transfer. However, failure to reach embryo transfer was more frequent with extended blastocyst culture, and the findings should not automatically be generalized to poor-prognosis patients, who were underrepresented in trials.
What Happens to an Embryo During the First Five Days?
After fertilization, the embryo begins dividing.
Day 1
The embryology laboratory confirms fertilization, commonly by identifying the expected pronuclei.
Day 2
The embryo continues dividing into several cells.
Day 3
The embryo is generally at the cleavage stage and consists of multiple blastomeres.
Embryologists assess features such as:
Cell number.
Cell symmetry.
Fragmentation.
Other morphological characteristics.
Day 4
Compaction occurs and the embryo develops toward the morula stage.
Day 5 and Day 6
Some embryos develop into blastocysts.
The blastocyst contains two important cell populations:
The inner cell mass, which contributes to formation of the fetus.
The trophectoderm, which contributes substantially to placental development.
Not every Day 3 embryo will reach the blastocyst stage.
What Is a Day 3 Embryo Transfer?
Day 3 transfer means transferring an embryo while it remains at the cleavage stage.
The embryology team selects embryos using their development and morphology during the first few days.
A major feature of this strategy is that the embryo does not need to remain in extended laboratory culture for several additional days.
That can become relevant when only a small number of embryos are available.
What Is a Day 5 Embryo Transfer?
In a Day 5 strategy, embryos remain in culture until they reach the blastocyst stage.
The additional time provides more developmental information.
Some embryos that appeared promising on Day 3 stop developing before blastulation.
Others continue and reach a transferable or freezable blastocyst stage.
Extended culture therefore provides additional selection.
It does not make an embryo biologically stronger simply because it remains in the laboratory for two additional days.
Why Is Blastocyst Transfer Commonly Used?
Several potential advantages explain its widespread use.
Blastocyst culture allows additional developmental selection.
The developmental timing is closer to when an embryo naturally reaches the uterine cavity.
When several embryos are available, it can help identify a candidate for single embryo transfer.
Blastocyst development is also usually required for modern trophectoderm biopsy when PGT is planned.
These advantages are particularly relevant when a patient has several normally developing embryos.
Does Day 5 Transfer Have a Higher Success Rate?
When outcomes are measured per fresh embryo transfer, blastocyst-stage transfer generally performs better in women with a good prognosis.
The 2026 Cochrane review included 36 randomized trials involving more than 8,000 participants and found that live birth per fresh transfer was probably higher with blastocyst transfer.
However, this does not answer the entire question.
Patients usually want to know the chance of eventually having a baby from all embryos generated by one egg retrieval.
That is the cumulative live-birth rate.
Per-transfer Success vs Cumulative Live Birth
This distinction is essential.
With blastocyst culture, some embryos stop developing before transfer.
The embryos that do reach blastocyst have therefore undergone additional developmental selection.
Success per transfer can consequently look higher.
With Day 3 strategies, more embryos may remain available for transfer or cryopreservation, but a patient may need more transfers before achieving pregnancy.
A large multicenter randomized trial involving 1,202 good-prognosis women illustrates this difference.
Cumulative live-birth rates were almost identical: 58.9% after a blastocyst-stage strategy versus 58.4% after a cleavage-stage strategy during follow-up.
However, women in the blastocyst group required fewer embryo transfers on average to achieve live birth.
Therefore, the statement “Day 5 has a better success rate” needs another question:
Better per transfer, or better per egg-retrieval cycle?
Why Not Culture Every Embryo to Day 5?
Because extended culture has a potential disadvantage.
Some embryos will not reach blastocyst.
A patient may therefore have embryos on Day 3 but no embryo suitable for transfer by Day 5.
The updated Cochrane review found a higher failure-to-transfer rate with blastocyst-stage culture and a lower proportion of women with surplus embryos available for freezing.
This matters increasingly as embryo number decreases.
What if Only Two or Three Embryos Are Available?
This is where individualized decision-making becomes particularly important.
When many embryos are available, waiting provides useful selection.
When only two or three embryos exist, there may be very little to select between.
Some fertility teams may therefore consider cleavage-stage transfer or cryopreservation rather than exposing every available embryo to extended culture.
A 2026 retrospective cohort study involving patients with only two to four Day 3 embryos found a lower cumulative live-birth rate among those whose entire embryo cohort underwent extended blastocyst culture compared with cleavage-stage management. Because the study was observational, it cannot establish that Day 3 is universally superior, but it reinforces the need not to extrapolate good-prognosis data to patients with limited embryo numbers.
Is Day 3 Better When Embryo Number Is Low?
It may be a reasonable strategy in selected patients, but it is not automatically better.
Day 3 transfer may be considered when:
Very few embryos are available.
Previous cycles showed repeated failure to reach blastocyst.
The laboratory believes extended culture offers little additional selection value.
Other individual clinical or laboratory factors favor earlier transfer.
Embryo number is only one component of the decision.
Does Transferring an Embryo on Day 3 “Save” It?
This is a common but oversimplified idea.
Sometimes patients are told that an embryo that stops developing in the laboratory would have survived if it had been transferred earlier.
That cannot be assumed.
If the embryo has major chromosomal or developmental abnormalities, transfer to the uterus does not guarantee continued development.
At the same time, we cannot know the counterfactual outcome for every individual embryo that stopped during extended culture.
The useful clinical question is therefore not whether “the uterus is always better than the incubator,” but whether the additional selection gained by extended culture is worth the risk of losing transfer opportunities in that particular patient.
Does a Good Day 3 Embryo Always Become a Good Blastocyst?
No.
Day 3 morphology provides useful information but has limited predictive accuracy.
An apparently excellent cleavage-stage embryo may arrest later.
A less impressive Day 3 embryo may continue to a usable blastocyst.
ASRM has noted that Day 2–3 cell number and fragmentation provide some information about blastocyst potential, but reliable criteria that identify which embryos will become viable blastocysts remain unavailable.
What Does Embryo Arrest Between Day 3 and Day 5 Mean?
Embryo arrest means development stops or becomes markedly abnormal.
Possible contributing factors include:
Chromosomal abnormalities.
Oocyte-related factors.
Sperm-related factors.
Cellular or metabolic problems.
Laboratory-related influences.
A single cycle with embryo arrest usually cannot identify the precise cause.
It should not automatically be interpreted as proof of an egg, sperm or laboratory problem.
Are Day 6 Blastocysts Usable?
Yes.
Many normal pregnancies result from blastocysts that reach the appropriate stage on Day 6.
ASRM's 2024 PGT-A committee opinion cites data in which euploid Day 6 blastocysts had outcomes that could be comparable with euploid Day 5 blastocysts, although developmental speed may still contribute to embryo prioritization in some laboratories.
Day 5 good and Day 6 bad is therefore not an appropriate rule.
What About Day 7 Blastocysts?
Some laboratories extend culture to Day 7 in selected cycles.
Day 7 blastocysts can produce healthy pregnancies and live births.
However, average implantation potential may be lower and some datasets report higher aneuploidy rates than among faster-developing blastocysts.
Laboratory policies therefore differ regarding Day 7 culture.
Does PGT-A Require Blastocyst Culture?
Usually, yes.
Modern PGT-A generally involves biopsy of several trophectoderm cells from a blastocyst.
The embryo usually reaches biopsy stage on Day 5 or Day 6, and occasionally Day 7.
After biopsy, the embryo is generally vitrified while genetic results are processed, followed later by frozen embryo transfer.
If PGT is part of the treatment plan, reaching blastocyst becomes a necessary stage of that strategy.
Does Reaching Blastocyst Mean the Embryo Is Chromosomally Normal?
No.
Blastocyst development demonstrates that an embryo has continued developing to an advanced stage.
It does not confirm euploidy.
A morphologically excellent blastocyst may still be aneuploid.
A lower-grade blastocyst may be euploid.
Morphology and PGT-A therefore provide different types of information.
Does Day 5 Mean the Transfer Must Be Fresh?
No.
Embryo stage and fresh-versus-frozen transfer are separate decisions.
Possible strategies include:
Fresh Day 5 blastocyst transfer.
Frozen Day 5 blastocyst transfer.
Frozen Day 6 blastocyst transfer.
Cleavage-stage embryo freezing in laboratories that use that strategy.
A freeze-all approach may be chosen because of:
OHSS risk.
Hormonal environment.
Endometrial considerations.
PGT.
Or the overall treatment strategy.
Is Blastocyst Culture More Useful When Many Embryos Exist?
Often, yes.
If several embryos are developing normally, the main challenge becomes selecting which embryo should be transferred first.
Extended culture provides additional developmental information and can support single embryo transfer while preserving additional blastocysts for later use.
This is one reason ASRM has supported blastocyst transfer particularly in good-prognosis patients.
Can Day 5 Reduce the Need to Transfer Multiple Embryos?
It can help.
Because selected blastocysts may have higher implantation potential in suitable patients, transferring one blastocyst can provide a good chance of pregnancy while reducing the risk created by transferring multiple embryos.
The modern goal of IVF is not simply a positive pregnancy test.
It is a healthy singleton live birth whenever possible.
Does Day 5 Increase Twin Pregnancy?
Not necessarily.
The most controllable factor is the number of embryos transferred.
Transferring one blastocyst avoids the large additional multiple-pregnancy risk associated with transferring two separate embryos.
A single embryo can rarely divide and produce monozygotic twins, so single embryo transfer does not reduce twin risk to zero.
Why Not Transfer Two Blastocysts to Increase Success?
Transferring two embryos may increase pregnancy probability in some situations, but it also increases multiple gestation risk.
Twin pregnancy carries additional maternal and neonatal risks.
Therefore embryo number should not simply be used as a tool to maximize the pregnancy rate.
Age, prognosis, previous treatment and embryo quality should guide the decision.
Is Miscarriage Lower After Day 5 Transfer?
The 2026 Cochrane review found that blastocyst-stage transfer may result in little or no difference in miscarriage after fresh transfer, although certainty of evidence was limited.
Blastocyst culture should therefore not be presented as a method that prevents miscarriage.
Are There Other Potential Disadvantages of Extended Culture?
Beyond failure to reach transfer, obstetric outcomes are increasingly studied.
The 2026 Cochrane review found that cumulative moderate preterm birth may be higher with blastocyst-stage strategies in available randomized evidence, although long-term data remain limited and further research is needed.
This does not mean blastocyst transfer is unsafe.
It means evaluation of an IVF strategy should include live birth and obstetric outcomes rather than pregnancy rate alone.
Why Do IVF Laboratories Have Different Day 3/Day 5 Policies?
Extended culture depends not only on embryo biology but also on laboratory performance.
Important factors include:
Incubator performance.
Temperature and gas stability.
Culture systems and media.
Embryologist experience.
Embryo-assessment protocols.
The laboratory's own blastulation rates.
ASRM has emphasized that laboratory expertise and culture conditions are important when deciding whether blastocyst culture should be routinely offered.
A strategy that performs well in one laboratory should not automatically be assumed to produce identical results elsewhere.
Must the Decision Be Made Before IVF Starts?
A preliminary strategy can be discussed before stimulation, but the final plan may change.
The team may initially intend to culture to blastocyst.
If only a small number of embryos remain on Day 3, the plan may be reconsidered.
In contrast, when PGT has already been selected, reaching the blastocyst stage is usually required.
Flexibility is therefore part of individualized embryo management.
What if Many Embryos Are Developing on Day 3?
This is the setting in which extended culture often has the greatest selection value.
The embryology team can observe:
Which embryos reach blastocyst.
Which blastocyst should be prioritized.
Which additional embryos can be vitrified.
Whether biopsy for PGT is possible.
The purpose remains selection rather than biologically “strengthening” embryos.
What if No Blastocysts Developed in a Previous Cycle?
The entire cycle should be reviewed rather than focusing only on Day 5.
Useful information includes:
Number of retrieved oocytes.
Number of mature oocytes.
Fertilization rate.
Day 2–3 development.
When embryo arrest occurred.
Maternal age.
Male-factor findings.
Laboratory observations.
A later cycle may involve a different transfer strategy, including discussion of Day 3 transfer, but the decision should not be based solely on the assumption that the uterus would necessarily rescue an embryo that arrests in culture.
Does Maternal Age Affect the Decision?
Aneuploidy becomes more common as oocyte age increases.
Extended culture does not correct chromosomal abnormalities.
When several embryos are available, blastocyst culture may help with developmental selection.
When only one or two embryos are available, however, the value of additional selection becomes less straightforward.
Maternal age and embryo number therefore need to be considered together.
What About Diminished Ovarian Reserve?
Diminished ovarian reserve does not automatically mean every oocyte has poor quality, but it may result in fewer oocytes and fewer embryos.
This makes the culture decision especially relevant.
A patient who repeatedly produces one or two embryos is in a different situation from a patient with ten normally fertilized oocytes.
For more information, see Diminished Ovarian Reserve: Does Low AMH Mean Poor Egg Quality and When Is IVF Needed?.
Where Does This Decision Fit Into the IVF Process?
The choice between Day 3 and Day 5 is one part of the complete IVF pathway.
It follows ovarian stimulation, egg retrieval and fertilization and precedes transfer or cryopreservation.
The decision cannot therefore be separated from ovarian response, mature-oocyte number, fertilization results and embryo development.
For the full pathway, see IVF From Fertilization to Embryo Transfer: What Happens at Each Stage?.
Common Mistakes When Comparing Day 3 and Day 5
Common mistakes include:
Assuming Day 5 is superior for every patient.
Comparing pregnancy per transfer without considering cumulative live birth.
Ignoring patients who never reach transfer.
Believing the laboratory makes embryos stronger by keeping them until Day 5.
Assuming every Day 3 embryo is inferior to a blastocyst.
Assuming Day 6 blastocysts are unusable.
Believing that transferring two embryos is automatically better.
Applying evidence from good-prognosis patients to women with very few embryos.
Conclusion
Day 3 and Day 5 embryo transfer are not competing strategies in which one is universally correct.
Blastocyst-stage transfer provides additional developmental information and can improve embryo selection. In women with a good prognosis, it probably increases live birth per fresh transfer.
However, extended culture also increases the possibility that no embryo reaches the transfer stage, which becomes increasingly relevant when only a small number of embryos are available.
A higher success rate per transfer also does not necessarily mean an equally large improvement in cumulative live birth from all embryos generated in one retrieval cycle.
The appropriate strategy therefore depends on:
Embryo number.
Embryo development.
Maternal age.
Previous IVF history.
Whether PGT is planned.
Embryology laboratory performance.
The overall treatment goal.
For some patients, waiting to blastocyst is the most informative and efficient strategy.
For others, preserving the opportunity for cleavage-stage transfer may be reasonable.
If you are planning IVF or have an embryo report from a previous cycle and want to understand why Day 3 or Day 5 transfer may be considered in your case, you can contact Safemedigo on WhatsApp for a preliminary review of your egg-retrieval, fertilization and embryo-development results.
Frequently Asked Questions
Is Day 5 embryo transfer always better than Day 3?
No. Day 5 can be particularly useful when several embryos are developing, while Day 3 may be considered in selected patients with very limited embryo numbers or other individual factors.
What happens if none of my embryos reach Day 5?
There will be no blastocyst available for transfer or freezing from that group. This risk is one reason embryo number matters when choosing extended culture.
Would an embryo that stopped in the laboratory have survived if transferred on Day 3?
It is impossible to know with certainty. Earlier transfer cannot guarantee continued development of an embryo with a major biological problem.
Is a Day 6 blastocyst worse than a Day 5 blastocyst?
Not necessarily. Day 6 blastocysts can produce healthy pregnancies and live births, particularly when other embryo characteristics are favorable.
Does PGT-A require blastocyst development?
Usually yes. Modern PGT-A generally requires a trophectoderm biopsy from an embryo that has reached the blastocyst stage, commonly on Day 5 or Day 6.
